Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Mar;3(3):305-7.
doi: 10.2217/imt.10.113.

Integrin antagonists for transplant immunosuppression: panacea or peril?

William H Kitchens, Christian P Larsen, Mandy L Ford
Editorial

Integrin antagonists for transplant immunosuppression: panacea or peril?

William H Kitchens et al. Immunotherapy. 2011 Mar.
No abstract available

PubMed Disclaimer

References

    1. Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant. 2010;10(3):535–546. - PubMed
    1. Evans R, Patzak I, Svensson L, et al. Integrins in immunity. Journal of Cell Science. 2009;122(Pt 2):215–225. - PubMed
    1. Cox D, Brennan M, Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov. 2010;9(10):804–820. - PubMed
    1. Isobe M, Suzuki J, Yamazaki S, Sekiguchi M. Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice. Transplantation. 1996;62(3):411–413. - PubMed
    1. Paul LC, Davidoff A, Benediktsson H, Issekutz TB. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation. 1993;55(5):1196–1199. - PubMed

Publication types

MeSH terms

LinkOut - more resources